![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|15|1|80-89
ISSN: 1389-4501
Source: Current Drug Targets, Vol.15, Iss.1, 2014-01, pp. : 80-89
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Molecular Architecture of Tumor Suppressor p53
Current Topics in Medicinal Chemistry, Vol. 8, Iss. 15, 2008-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Interaction of Tumor Suppressor p53 with DNA and Proteins
Current Pharmaceutical Biotechnology, Vol. 11, Iss. 1, 2010-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Peptide Activators of the p53 Tumor Suppressor
Current Pharmaceutical Design, Vol. 17, Iss. 6, 2011-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?
Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. :